John Lepore is Senior Vice President, Head of Research at GSK leading a team of more than 1,000 researchers, scientists and physicians working to identify new drug targets, discover novel drug candidates, and demonstrate safety and proof of mechanism in clinical studies. John’s team focuses on the modulation of the immune system and human genetics to identify novel drug targets with a higher probability of success. John currently serves on the Board of Directors of ViiV Healthcare, the Scientific Advisory Boards of Medicxi Ventures and Hatteras Ventures, the BIO Health Section Governing Board, and the P...read more